Model Checkpoint Epoch: 5.0
Evaluation Model Used: gpt-5
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is an important indicator for identifying neonatal undernutrition. We recommend using BF% as a measure of undernutrition in neonates because it is a more accurate measure than birth weight percentiles. Our data suggest that BF% may be a stronger predictor of neonatal morbidity than birth weight percentiles. This may be because BF% reflects the overall nutrient status of the infant rather than just weight. However, both BF% and birth weight percentiles should be considered when evaluating the risk of neonatal morbidity. Future studies should continue to explore the relationship between these measures and neonatal health. In addition, clinicians should consider BF% when determining the appropriate interventions to reduce the risk of undernutrition in neonates.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.9
Reasoning:
The assistant’s answer aligns with the study’s findings: it concludes that body fat percentage (BF%) is a stronger indicator of neonatal undernutrition and more closely associated with neonatal morbidity than birth weight percentiles. It correctly states that BF% appears to be a stronger predictor and appropriately notes that both measures can be considered. However, it slightly overgeneralizes by calling BF% “more accurate” without specifying that the evidence is based on stronger association with morbidity, and it omits the useful nuance that BF% can identify undernourished infants who are appropriately grown and exclude small but not at-risk neonates.

conciseness: 0.5
Reasoning:
The response does provide a clear answer that BF% is a better measure, which addresses the question. However, it is not concise: it adds multiple extraneous sentences (recommendations, calls for future studies, and general rationale) beyond the core conclusion. A more concise reply would be a brief yes with a short justification.

relevance: 0.6
Reasoning:
The response is relevant and correctly conveys that BF% is a stronger predictor of neonatal morbidity than birth weight percentiles, aligning with the context. However, it does not reference or quote specific findings from the provided context (e.g., the higher OR for BF%), which the evaluation criterion emphasizes. It also adds recommendations beyond the question.

coherence: 0.9
Reasoning:
The response directly addresses the question, maintains a clear position that BF% is a better measure than birth weight percentiles, and provides a logical rationale (BF% reflects nutrient status, stronger association with morbidity). It is organized and coherent, albeit slightly verbose and with some unnecessary generalities (e.g., recommendations and future studies) that are not essential to the question. Overall, it is coherent and well-structured.

helpfulness: 0.8
Reasoning:
The response directly answers the question by stating that BF% is a stronger predictor of neonatal morbidity than birth weight percentiles and gives a reasonable rationale. It is generally aligned with the ground truth. However, it lacks specific insights from the study such as BF% helping identify appropriately grown but undernourished neonates and excluding small neonates not at risk, and it does not reference the comparative strength explicitly (e.g., stronger association). It also includes some generic recommendations that add little to the core question.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The healed time of the lesion after the combined treatment of endovascular revascularization, surgery, and orthotics did not differ significantly from other cases of Charcot arthropathy. In addition, the infection control rates were similar to those reported in other studies. The results suggest that this approach may be an effective alternative to the management of ischemic Charcot foot. However, further studies are needed to confirm these results. Nevertheless, it is important to note that each case must be evaluated individually, taking into account the severity and extension of the lesion, as well as the general condition of the patient. This allows us to establish the best therapeutic strategy for each case.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.2
Reasoning:
The response makes unsupported claims (e.g., that healing time and infection control were similar to other Charcot cases) not provided in the context. It omits key results, such as the 90% limb salvage rate and the mean healing time (~197 days), and does not clearly answer the core question that ischemic Charcot foot requires a different approach emphasizing necessary revascularization to support surgical/orthopedic treatment and avoid amputation. Overall, it is inaccurate and incomplete.

conciseness: 0.2
Reasoning:
The response is indirect and wordy, offering generic statements about healing times and the need for individualized care without clearly addressing the question. It fails to concisely state the key point from the context/ground truth: ischemic Charcot foot requires revascularization to support surgical and orthopedic treatment for limb salvage and to avoid amputation. The added remarks about significance and further studies are not necessary to answer the question.

relevance: 0.2
Reasoning:
The assistant’s response is only loosely relevant to the question and context. It does not reference any concrete data or quotes from the provided context (e.g., 90% limb salvage or mean healing time ~197 days) and introduces unsupported claims about “no significant differences” and infection control rates not present in the text. It also fails to capture the key point from the ground truth that revascularization is necessary to support surgical and orthopedic treatment to avoid amputation and achieve limb salvage.

coherence: 0.3
Reasoning:
The response is grammatically coherent but does not directly address the question of whether ischemic Charcot foot represents a different disease requiring different treatment. It focuses on healing time and infection control without tying these points to the central inquiry. The claim of “no significant difference” is unsupported and the phrase “effective alternative” is vague and unclear. Overall, the answer is tangential, lacks a clear stance, and fails to synthesize the provided context into a coherent, directly relevant conclusion.

helpfulness: 0.2
Reasoning:
The response is not very helpful relative to the provided ground truth. It fails to address the key takeaway that in ischemic Charcot foot, revascularization is necessary to support surgical and orthopedic management to avoid major amputation and achieve limb salvage. It omits the central outcomes (90% limb salvage, mean healing time ~197 days) and instead makes unsupported comparisons (e.g., “did not differ significantly” and “similar infection control rates”) that are not grounded in the given data. It also hedges rather than directly answering whether ischemic Charcot foot requires a different treatment approach.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: In this prospective cohort study, we evaluated the long-term outcome of radical hysterectomy in patients with endometrial adenocarcinoma, who also had suspected gross cervical involvement. Radical hysterectomy was performed in 74 patients, while 112 patients received modified radical hysterectomy or 114 patients received simple hysterectomy. We found that there were no significant differences in age, performance status, body mass index, stage distribution, or adjuvant therapy among the three groups. The prognostic factors for overall survival (OS) were identified as age, tumor grade, peritoneal cytology status, and lymph node involvement, but type of hysterectomy was not an independent prognostic factor for local recurrence-free survival or OS. Moreover, patients treated by RH experienced longer operative times, higher rates of blood transfusion, and more severe urinary tract dysfunction. These findings suggest that radical hysterectomy may be unnecessary in all patients with endometrial cancer and suspected cervical involvement. Further studies are warranted to confirm these results. Patients should be offered optimal treatment based on their clinical characteristics and tumor histopathologic features. The choice of surgery should be individualized for each patient.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.7
Reasoning:
The answer accurately conveys the main findings: type of hysterectomy was not a prognostic factor for survival outcomes, and radical hysterectomy was associated with more perioperative morbidity (longer operative time, more transfusions, urinary dysfunction). It also appropriately suggests that RH may not be necessary and calls for further studies. However, it incorrectly characterizes the study as a prospective cohort (it was retrospective) and omits mentioning that PFS was also not improved. Overall, mostly correct with a notable study-design error.

conciseness: 0.6
Reasoning:
The answer conveys the key takeaway (no survival benefit with RH and more complications) but is verbose. It includes detailed cohort breakdowns and baseline characteristics that are not necessary to directly answer the question, plus generic counseling statements. A more concise response could have focused on the lack of prognostic/survival benefit and higher adverse events with RH, with a brief note that further study is needed.

relevance: 0.9
Reasoning:
The assistant’s response directly addresses the question using details from the provided context: it summarizes the study groups and endpoints, identifies the same prognostic factors (age, grade, peritoneal cytology, lymph node involvement), states that the type of hysterectomy was not an independent prognostic factor for survival, and notes higher operative burden and urinary tract dysfunction with radical hysterectomy—leading to the conclusion that RH may not be necessary. The main flaw is labeling the study as prospective (it was retrospective), and it omits PFS in the explicit list of outcomes where hysterectomy type was not prognostic. Overall, it is highly relevant to the question and consistent with the context.

coherence: 0.9
Reasoning:
The response is well-structured and directly addresses the question. It summarizes the study design, patient groups, key findings (no survival benefit by hysterectomy type, identified prognostic factors), and adverse events, then offers a clear conclusion that RH may not be necessary and calls for further studies. The narrative flows logically and remains coherent throughout. Minor issues (e.g., study labeled as prospective, omission of PFS mention) affect accuracy but not coherence.

helpfulness: 0.7
Reasoning:
The response summarizes the key findings relevant to the question: no survival benefit of radical hysterectomy, type of hysterectomy not an independent prognostic factor, and higher morbidity with RH. It offers an appropriate takeaway (RH may not be necessary for all and decisions should be individualized, with further studies needed). However, it inaccurately describes the study as prospective (it was retrospective), omits explicit mention of PFS, and adopts a first-person authorial tone. Despite these issues, it remains largely helpful and aligned with the ground truth.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD may be reduced by the following strategies: 1) Pancreatic fistula management: Early recognition and treatment of pancreatic fistulas should be emphasized. Proper fluid management and the use of prokinetics may help reduce the risk of delayed gastric emptying and pneumonia. 2) Multivisceral resection: Surgery should be performed with the aim of complete resection of the primary tumor and preservation of vital organ function. This approach may decrease the risk of complications and readmissions. 3) Prevention of ileus and delayed gastric emptying: Postoperative bowel rest should be avoided, and nasogastric suction and oral feedings should be instituted promptly. 4) Improved patient education: Patients should be counseled regarding postoperative expectations, including the possibility of readmission if symptoms persist. They should also be aware of signs of readmission and the importance of seeking timely medical attention. 5) Timely identification of readmission risk factors: Clinicians should be aware of the potential risk factors for readmission after PD, such as pancreatic fistula, multivisceral resection, prolonged initial hospital stay, and ICU admissions. Identification of these factors will allow for prompt interventions, thereby reducing the likelihood of readmission. 6) Optimization of perioperative care: Perioperative care should focus on minimizing the risk factors for readmission and ensuring proper postoperative care. The optimal management of comorbidities, nutrition, and pain control should be implemented. 7) Use of postdischarge surveillance: Monitoring patients closely after discharge will allow for early detection of complications and readmission. This strategy may involve telephone contact and regular visits with home-based nursing services. 8) Collaboration between surgeons, internists, and other specialists: All members of the surgical team should work together to develop a comprehensive plan for managing postoperative complications and readmissions. This plan should include early intervention protocols and referral guidelines for specialists. 9) Development of hospital-wide protocols: Institutions should create protocols for the prevention and management of postoperative complications and readmissions. These protocols should cover the entire continuum of care and ensure standardization of practice. 10) Patient engagement: Patients should be actively engaged in their recovery process through patient education, shared decision-making, and regular communication. This approach will foster a collaborative relationship between patients and their health care providers.
These strategies will require further evaluation, validation, and implementation to determine their efficacy in reducing readmissions. However, they provide a framework for the development of targeted interventions to improve outcomes and reduce health-care costs.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.6
Reasoning:
The answer mentions key predictors like pancreatic fistula and multivisceral resection, aligning with the study’s independent associations. It also notes prolonged initial stay and ICU admission, which are consistent with the reported risk factors. However, it misses a central finding: half of readmissions occur within 7 days, implying prevention efforts should focus on early postdischarge care. Some recommendations are generic or questionable (e.g., simultaneous nasogastric suction and early oral feeding), and the response does not clearly tie proposed interventions to the study’s specific findings on timing and causes of early vs late readmissions.

conciseness: 0.2
Reasoning:
The response is verbose and generic, offering a long list of strategies rather than a concise synthesis of the key findings. It fails to succinctly highlight the main points from the context: that pancreatic fistula and complexity of the initial resection are independent predictors of readmission, and that prevention efforts should focus on early (≤7 days) readmissions, which constitute half of all cases. Therefore, it does not answer the question concisely.

relevance: 0.4
Reasoning:
The response offers general prevention strategies and mentions some risk factors that align with the context (pancreatic fistula, multivisceral resection, prolonged stay, ICU admission). However, it does not reference or quote any specific statements from the provided context and misses the key takeaway that half of readmissions occur within 7 days and efforts should focus on preventing early readmissions. It therefore only partially aligns with the context and lacks the required direct reference.

coherence: 0.6
Reasoning:
The response is well-organized and generally on-topic, offering a structured list of prevention strategies that aligns broadly with the question. However, several points are vague or internally inconsistent (e.g., recommending both nasogastric suction and prompt oral feeding; implying prokinetics reduce pneumonia), and the answer does not clearly prioritize early readmissions or tie recommendations to the identified risk factors in a focused way. These issues reduce coherence despite the overall structure.

helpfulness: 0.6
Reasoning:
The assistant provides a broad set of strategies that generally align with preventing readmissions after PD, acknowledging key risk factors like pancreatic fistula and multivisceral resection. It also touches on early complications (ileus, delayed gastric emptying, pneumonia) and post-discharge surveillance, which are relevant given that many readmissions occur early. However, the response is generic, includes some questionable specifics (e.g., routine nasogastric suction alongside early oral feeding), and does not clearly emphasize that early readmissions constitute half of all readmissions or that complexity of resection and pancreatic fistula are the primary independent predictors. It also misses the point that no postoperative biochemical variables predicted readmission.

================================================================================
Average correctness Score: 0.55
Average conciseness Score: 0.36
Average relevance Score: 0.48
Average coherence Score: 0.67
Average helpfulness Score: 0.525
